G. Salbert et al., RETINOIC ACID RECEPTORS AND RETINOID-X RECEPTOR-ALPHA DOWN-REGULATE THE TRANSFORMING GROWTH FACTOR-BETA(1) PROMOTER BY ANTAGONIZING AP-1 ACTIVITY, Molecular endocrinology, 7(10), 1993, pp. 1347-1356
Overexpression of the multifunctional growth factor transforming growt
h factor-beta1 (TGFbeta1) has been connected to numerous diseases in h
uman. TGFbeta1 expression is largely governed by three AP-1 binding si
tes located in two different promoters of this gene. We have examined
the ability of retinoid receptors to inhibit the activity of the two p
romoters (especially the promoter 1) by cotransfection assays in the h
epatocellular carcinoma cell line HepG2. When the TGFbeta1 promoter ac
tivity is induced by 12-O-tetradecanoyl phorbol-13-acetate (an activat
or of AP-1-controlled gene transcription), this activity can be strong
ly repressed by retinoic acid receptor-alpha (RARalpha), RARbeta, or r
etinoid X receptor-alpha (RXRalpha) as well as other members of the nu
clear receptor family. Repression was hormone dependent and a function
of receptor concentration. Heterodimerization of RARa or RARbeta with
RXRalpha did not modify the inhibition activities of these receptors,
indicating that heterodimer formation is not required for antagonizin
g of AP-1 activity. On further examining the anti-AP-1 activity of RXR
alpha we observed that three different AP-1-controlled promoters (TGFb
eta1, collagenase, and cFos) can be inhibited. Using gel shift assays,
we demonstrated that RXRalpha inhibits Jun and Fos DNA binding and th
at 9-cis RA enhances this inhibition, suggesting that a mechanism invo
lving direct protein-protein interaction between RXR and AP-1 componen
ts mediates the inhibitory effect observed in vivo. Transfection analy
ses with RXRalpha point mutations revealed that residues L422, C432, a
nd, to a lesser extent, residues L418 and L430, are involved in ligand
-induced anti-AP1 activity of RXRalpha in vivo. Thus both types of ret
inoid receptors can inhibit AP-1-activated promoters, including the TG
Fbeta1 gene promoter, via a mechanism that involves protein-protein in
teraction.